The impact of an educational program on HCV patient outcomes using boceprevir in community practices (OPTIMAL trial)

OBJECTIVES: Although effective, direct acting antiviral (DAA) therapies for genotype 1 (GT 1) hepatitis C virus (HCV) have been associated with compliance challenges. Additionally, treatment at predominantly community-based centers has been associated with low retention of patients on treatment and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Therap Adv Gastroenterol
Main Authors: Poordad, Fred, Rustgi, Vinod, Brown, Robert S., Patel, Vishal, Kugelmas, Marcelo, Regenstein, Fredric, Balart, Luis, LaBrecque, Douglas, Brown, Kimberly, Avila, Mark, Biederman, Michael, Freed, Glenn, Smith, Richard, Bernstein, Marc, Arnold, Hays, Cahan, Joel, Fink, Scott, Katkov, William, Massoumi, Hatef, Harrison, Stephen
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4530435/
https://ncbi.nlm.nih.gov/pubmed/26327916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X15588876
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados